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1076-42 Subsets of CD8+ T Cells Are Expanded in Stable 
Coronary Artery Disease 
Lena Jonasson. Anders Wikby, Andrea Tompe, Research Center of Cardiovascular and 
Metabolic Diseases, Hdgland Hospital, Eksj6, Sweden, Department of Natural Sciences 
and Biomedicine, University College of Health Sciences, J6nk6ping, Sweden. 
Background: There is evidence for a systemic immune response, involving continuous 
T cell activation, in stable coronary artery disease (CAD). So far, the type of this T cell 
response is not fully understood. In this study we have examined certain phenotypical 
properties of CO8+ T cells in stable angina patients. 
Methods: Forty-four men (< 60 years of age) with stable angina and angiographically 
verified CAD were included as well as 70 healthy controls. T cell phenotypes in periph- 
eral blood were determined by 3 colour flow cytometry using triples of monoclonal anti- 
bodies against the following surface antigens and activation markers: CD3, CD4, CD8, 
CD57, CD28 and HLA-DR. 
Results: The total number of CD8+ cells did not differ significantly between patients and 
controls (577+~?.93 vs476 +~95 cells/mm3). However, the proportions of CD8+ ceils 
expressing HI.A-DR and CD57 were significantly increased in the patient group while the 
percentage of CD28-negative cells was decreased. Data are presented in the table. 
Conclusion: CD8+ cells are activated in patients with stable angina and there is an 
expansion of a certain CD8+ phenotype expressing CD57 but not CD28. This phenotype 
has been associated with suppressive activity and its role in stable CAD may be to con- 
trol an antigen-driven immune response. 
Patients Controls p 
CD57+ CDS+ 
cells/mm 3 317+_234 220_+258 0.04 
% of total CDS+ 47 37 0.005 
CD28- CD8+ 
cells/mm 3 363+~?.64 262_+282 0.06 
% of total CO8+ 52 45 0.05 
HLA-DR+ CD8+ 
cells/mm 3 159-+111 101 _+73 0.003 
% of total CD8+ 25 20 0.01 
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801-2 Impact of New Diagnostic Criteria for Myocardial 
Infarction in an Unselected United Kingdom Cohort 
With Suspected Cardiac Chest Pain 
Jasoer Trevelvan, Shane Gieowarsingh, Mauro Lencioni, Edward W. Needham, Stehpen 
C. Smith, Raj K. Mattu, University Hospitals of Coventry and Warwickshire, Covent~ 
United Kingdom. 
Background: The Joint European Society of Cardiology/American College of Cardiology 
Committee's revised definition of myocardial infarction (MI) proposes the primacy of the 
cardiac troponins in the diagnosis of MI, with CK-MB a recommended alternative. These 
recommendations may increase the incidence of MI and reduce case fatality, but this has 
not been examined prospectively. We therefore assessed the diagnostic impact of these 
changes in an unselected UK cohort with suspected cardiac chest pain 
Methods: We enrolled all patients admitted with suspected cardiac chest pain over 6 
months, with usual care provided by the attending physician with serial ECGs and creat- 
ine kinase (CK)/aspartate transaminase (AST). Additional blinded measurements of CK- 
MB mass and troponin T (cTnT) were made. After discharge a blinded panel reviewed 
the case notes and reached a World Health Organisation diagnosis utilising electrocar- 
diograms/CK/AST, a CK-MB diagnosis using CK-MB as the gold-standard cardiac 
marker at 2 discriminator values (5 and 10mg/L), and a cTnT diagnosis in accordance 
with the new recommendations. 
Results: 401 patients were enrolled. In comparison to the WHO diagnosis, CK-MB at 
5mg/L diagnosed a further 23.2% (36 of 155) MIs, 11 patients with high risk unstable 
angina pectoris (UAP) and excluded MI in 4 patients, with overall 51 (12.7%) patients 
having a significant diagnostic adjustment. At 10rag/L, CK-MB diagnosed 126 patients as 
MI, 35 as high risk UAP, with a diagnostic alteration in 54 (13.5%) patients. The revised 
criteria utilising cTnT diagnosed a further 26.1% (42 of 161) MIs, and excluded MI in 4 
patients, with 1t.5% of patients having a significant diagnostic alteration. Sedal CK and 
AST measurements had a diagnostic sensitivity of 70.5% and 69.0% respectively for MI. 
Conclusion: Introduction of the revised diagnostic criteria for MI diagnoses an additional 
26.1% of patients with MI. CK-MB diagnoses a broadly similar cohort as MI at a lower 
discriminator value, but not at the higher threshold. Serial CK/AST and ECGs mis-diag- 
nose 11.5% of all chest pain admissions when compared with the new definition for MI. 
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801-1 Six-Month Prognosis of Patients Diagnosed With 
Myocardial Infarction by World Health Organization 
Criteria Versus New European Society Cardiology/ 
American College Cardiology Troponin-Based Criteria 
Jasoer Trevelvan. Mauro Lencioni, Shane Gieowarsingh, Edward W. Needham, Stephen 
C. Smith, Raj K. Mattu, University Hospitals of Coventry and Warwickshire, Covent~ 
United Kingdom. 
Background: The Joint European Society of Cardiology/American College of Cardiology 
Committee's revised definition of myocardial infarction (MI) proposes the primacy of the 
cardiac troponins in the diagnosis of MI. The committee state that these changes will 
reduce fatality, but this has never been tested prospectively. We assessed the prognosis 
of patients diagnosed as MI by the new versus World Health Organisation (WHO) criteria 
over 6 months. 
Methods: All patients admitted with suspected cardiac chest pain were enrolled. A 
blinded panel reached a WHO diagnosis utilising serial electrocardiograms/creatine 
kinase/aspartate transaminase, and a troponin T (cTnT) diagnosis in accordance with the 
new criteria. 6 month major adverse cardiovascular events (MACE) were recorded 
(table). Kaplan-Meier survival analysis was performed by time to first event. 
Results: 401 patients were enrolled. 161 patients had a cTnT MI, with 42 of these being 
WHO negative. All MACE events apart from CABG were more common in cTnT positive 
patients, irrespective of WHO status. 
cTnT/WHO cTnT positive / WHO cTnT negative 
positive (n=119) negative (n=42) (n=240) 
Cardiac Death 8 (6.7%) 5 (11.9%) 3 (1.3%) (p=O.001) 
Non-fatal MI 9 (7.6%) 0 (0.0%) 0 (0.0%) (p<O.0001) 
PTCA 11 (9.2%) 4 (9.5%) 0 (0.0%) (p<0.0001) 
CABG 4 (3.4%) 3 (7.1%) 9 (3.8%) (p=ns) 
Readmission UAP 17 (14.3%) 6 (14.3%) 10 (4.2%) (p=O.001) 
Any MACE 32 (26.9%) 12 (28.6%) 17 (7.1%) (p<O.O001) 
Kaplan-Meier analysis demonstrates that the cTnT positive groups display almost identi- 
cal MACE-free survival, significantly inferior to cTnT negative patients (log rank Z 2 31.86, 
p<O.O0001 ).
Conclusion: cTnT positive /WHO negative patients have a similar prognosis to cTnT/ 
WHO positive patients. Troponin negative patients have a superior, but not entirely 
benign, prognosis. 
801-3 Validation of ACC-AHA 2000 Guidelines for the Risk 
Stratification of Patients With Non-ST Elevation Acute 
Coronary Syndromes 
Oscar Bazzino. Fernando Botto, Jos~ L. Navarro Estrada, Maria i. Sosa Liprandi, Juan J. 
Fuselli, Jos~ Santopinto, Rodolfo Ahuad, Roberto Nordaby, Simon Salzsberg, Alfredo 
Hirschson Prado, Jos~ Gant L6pez, Mario Russo, Marcelo Perez, Cados Bruno, Raul De 
Miguel, PACS Investigators, Buenos Aires, Argentina. 
Background: New recommendations have been recently developed regarding the risk 
stratification of non ST elevation acute coronary syndromes. We compared the preva- 
lence and prognostic value of new (2000) and past (t994) risk categories. Methods: This 
prospective multicenter cohort study included 1000 consecutive patientes admitted to 
CCU because of non-ST-elevation acute coronay syndromes. Baseline clinical and elec- 
trocardiographic data were recorded. Single assays of 3rd generation troponin T was 
performed after a median time of 9 hours from sympton onset. The primary endpoint was 
the 180-day incidence of the composite of death or myocardial infarction (D/AMI). 
Results: D/AMI occurred in 9.4% of patients at 180days. Event rates according to past 
and new guidelines are shown: 
Year 2000 Year 1994 
n ER% OR 95%CI p n ER% OR 95%CI p 
LR 78 1.3 0.11 0.01-0.83 0.005 52 1.9 0.17 0.02-1.30 0.053 
MR 273 6.2 0.55 0.32-0.95 0.03 537 8.4 0.75 0.49-1.10 0.19 
HR 649 11.9 2.50 1.41-4.23 0.0001 411 11.9 1.60 1.00-2.40 0.037 
ER: event rate, LR: low risk, MR: medium risk, HR: high risk, OR: odds ratio 
Receiver operating curves were 0.60+0.03 and 0.56+0.32 (p=NS), for the new and old 
classifications respectively. The new guidelines evidenced higher sensitivity (81% vs 
51%), and less specificity (37% vs 60%), with similar positive and negative predictive val- 
ues: 12% vs 12% and 95% vs 92%, respectively. Conclusions: An important conse- 
quence of the present guidelines is an increase of the high risk group, with a proportional 
reduction in the size of the medium risk group. The new guidelines are more sensitive 
and identified more hard events than the older reccomendations. 
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801-4 A Simple Risk Score for Prediction of 30-Day Morta l i ty  
in Patients With Acute Coronary Syndrome: Insights 
From GUSTO IV 
W.H. Wilson Tano. H/tinder S. Gurm, Marion Piedmonte, Elliot S. Barnathan, Judith 
Cooper, Robert M. Califl, Eric J. Topoi, Cleveland Clinic Foundation, Cleveland, Ohio. 
Background: Acute coronary syndrome (ACS) is a common illness with a significant 
early risk of death. A simple clinical risk score can provide a valuable tool for physicians 
in prognostication and better focusing of therapy in the more at-risk population. Previ- 
ously described risk scores have been derived from smaller populations thus limiting a 
wider application. 
Methods: We examined a total of 27 factors that were easily available at the initial bed- 
